Use of GeriKit to Better Phenotype Older Adults With Ischemic Heart Disease
- Conditions
- Ischemic Heart Disease
- Interventions
- Procedure: GeriKit Mobile Application
- Registration Number
- NCT05788666
- Lead Sponsor
- NYU Langone Health
- Brief Summary
This study seeks to expand the use of the NYU GeriKit mobile application ("app") in a diverse range of settings to better phenotype older patients, which will enhance both research and patient care.
- Detailed Description
This is a single-center proof of concept study of geriatric impairments and feasibility metrics through the use of the GeriKit software application in older adults with ischemic heart disease at the NYU Langone Medical Center. The GeriKit mobile application was developed to make geriatric assessment instruments easily accessible to clinicians who do not have subspecialty training in geriatrics. The GeriKit app has been used clinically but is untested in research settings.
Recruitment & Eligibility
- Status
- RECRUITING
- Sex
- All
- Target Recruitment
- 150
- Age ≥ 75
- Currently hospitalized for acute mycardial infarction (AMI), percutaneous coronary intervention (PCI), or coronary artery bypass grafting (CABG); or hospitalized for AMI, PCI, or CABG within the prior 4 weeks
- Capable of self-consent
- Understand and are able to perform study procedures in English
- Non-ambulatory
- Moderate or severe cognitive impairment (operationalized as known diagnosis of dementia)
- Unable or unwilling to consent
- Incarcerated
- Unable to use complete assessments in English
- Unable to complete geriatric assessment for other reasons
Study & Design
- Study Type
- INTERVENTIONAL
- Study Design
- SINGLE_GROUP
- Arm && Interventions
Group Intervention Description Geriatric Assessments using GeriKit App GeriKit Mobile Application Participants will receive comprehensive geriatric assessment via GeriKit app at baseline. All participants will complete a follow-up assessment via phone at 6 months. 20 of the 150 enrolled participants will continue onto a qualitative questionnaire after the completion of the 6-month follow up call.
- Primary Outcome Measures
Name Time Method Incidence of Mortality or Hospital Readmission Month 6 Binary outcome; determined by review of patient electronic health record (EHR) data at Month 6.
- Secondary Outcome Measures
Name Time Method Seattle Angina Questionnaire Short-Form (SAQ-7) Month 6 7-item questionnaire assessing functional status, angina and disease-specific health-related quality of life (HRQoL) over a four-week recall period. Responses generate a summary score ranging from 0-100, where 100 = full health, and 0 = worst health.
12-Item Short Form Survey (SF-12) Score Month 6 The SF-12 is a self-reported outcome measure assessing the impact of health on an individual's everyday life. It is often used as a quality-of-life measure. SF-12 consists of 12 questions that are scored in various ways. The total score range is 12-48; the higher the score, the higher the score, the better the physical and mental health functioning.
Trial Locations
- Locations (1)
NYU Langone Health
🇺🇸New York, New York, United States